2016
Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis
Tzouvelekis A, Herazo‐Maya J, Slade M, Chu J, Deiuliis G, Ryu C, Li Q, Sakamoto K, Ibarra G, Pan H, Gulati M, Antin‐Ozerkis D, Herzog EL, Kaminski N. Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis. Respirology 2016, 22: 486-493. PMID: 27761978, PMCID: PMC5352520, DOI: 10.1111/resp.12920.Peer-Reviewed Original ResearchConceptsTransplant-free survivalIdiopathic pulmonary fibrosisMMP-7 concentrationsMatrix metalloproteinase-7IPF patientsCause mortalityPulmonary fibrosisHealthy controlsMultivariate Cox proportional hazards modelCox proportional hazards modelPulmonary function parametersVariable clinical courseBaseline pulmonary function parametersProportional hazards modelIPF biomarkersProgressive diseaseClinical coursePoor prognosisPrognostic valueVital capacityIndependent biomarkerLung capacityPrognostic thresholdPlasma concentrationsMortality risk
2011
Diagnostic assessment of patients with interstitial lung disease
Gulati M. Diagnostic assessment of patients with interstitial lung disease. Npj Primary Care Respiratory Medicine 2011, 20: 120-127. PMID: 21509417, PMCID: PMC6549811, DOI: 10.4104/pcrj.2010.00079.Peer-Reviewed Original ResearchMeSH KeywordsBiopsyDiagnosis, DifferentialHumansLung Diseases, InterstitialReproducibility of ResultsRespiratory Function TestsTomography, X-Ray ComputedConceptsInterstitial lung diseaseChronic obstructive pulmonary diseaseLung diseaseSurgical lung biopsyObstructive pulmonary diseaseConnective tissue diseasePrimary care settingHistory of symptomsTomography chest scanILD formsLung biopsyRespiratory symptomsPulmonary diseaseClinical cluesPulmonary diagnosisTissue diseaseILD casesPhysical examinationDrug exposureGeneral practitionersDiagnostic evaluationCare settingsStructured historyChest scansDisease